{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:23:38Z","timestamp":1760909018027},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s10689-016-9939-8","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T08:44:05Z","timestamp":1477989845000},"page":"257-265","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway"],"prefix":"10.1007","volume":"16","author":[{"given":"Trine","family":"Levin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lovise","family":"M\u00e6hle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,1]]},"reference":[{"issue":"1","key":"9939_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng0994-22","volume":"8","author":"A Kamb","year":"1994","unstructured":"Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J et al (1994) Analysis of the p16 gene (CDKN2A) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8(1):23\u201326","journal-title":"Nat Genet"},{"key":"9939_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0196-97","volume":"12","author":"L Zuo","year":"1996","unstructured":"Zuo L, Weger J, Yang O, Goldstein AM, Tucker MA, Walker GJ, Hayward N, Dracopoli NC (1996) Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12:97\u201399","journal-title":"Nat Genet"},{"issue":"4","key":"9939_CR3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/1096-8628(20000814)93:4<257::AID-AJMG1>3.0.CO;2-8","volume":"93","author":"BB Biesecker","year":"2000","unstructured":"Biesecker BB, Ishibe N, Hadley DW, Giambarresi TR, Kase RG, Lerman C, Struewing JP (2000) Psychosocial factors predicting BRCA1\/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. Am J Med Genet 93(4):257\u2013263","journal-title":"Am J Med Genet"},{"issue":"6","key":"9939_CR4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1099-1611(200011\/12)9:6<504::AID-PON491>3.0.CO;2-R","volume":"9","author":"C Julian-Reynier","year":"2000","unstructured":"Julian-Reynier C, Sobol H, S\u00e9villa C, Nogu\u00e8s C, Bourret P, Network FCG (2000) Uptake of hereditary breast\/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network. Psycho Oncol 9(6):504\u2013510","journal-title":"Psycho Oncol"},{"issue":"1\u20133","key":"9939_CR5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1155\/1999\/581346","volume":"15","author":"JG Reichelt","year":"1999","unstructured":"Reichelt JG, Dahl AA, Heimdal K, M\u00f8ller P (1999) Uptake of genetic testing and pre-test levels of mental distress in Norwegian families with known BRCA1 mutations. Dis Markers 15(1\u20133):139\u2013143","journal-title":"Dis Markers"},{"key":"9939_CR6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1023\/A:1025864703405","volume":"5","author":"TL Bodd","year":"2003","unstructured":"Bodd TL, Reichelt J, Heimdal K, Moller P (2003) Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway. J Genet Couns 5:405\u2013417","journal-title":"J Genet Couns"},{"issue":"2","key":"9939_CR7","first-page":"169","volume":"4","author":"JP Struewing","year":"1995","unstructured":"Struewing JP, Lerman C, Kase RG, Giambarresi TR, Tucker MA (1995) Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 4(2):169\u2013173","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"9939_CR8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/sj.bjc.6600253","volume":"86","author":"C Foster","year":"2002","unstructured":"Foster C, Evans DG, Eeles R, Eccles D, Ashley S, Brooks L, Davidson R, Mackay J, Morrison PJ, Watson M (2002) Predictive testing for BRCA1\/2: attributes, risk perception and management in a multi-centre clinical cohort. Br J Cancer 86(8):1209\u20131216","journal-title":"Br J Cancer"},{"issue":"12","key":"9939_CR9","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/jnci\/94.12.894","volume":"94","author":"DT Bishop","year":"2002","unstructured":"Bishop DT, Demenais F, Goldstein AM, Bergman W, Bishop JN, Bressac-de Paillerets B, Chompret A, Ghiorzo P, Gruis N, Hansson J, Harland M, Hayward N, Holland EA, Mann GJ, Mantelli M, Nancarrow D, Platz A, Tucker MA, Melanoma Genetics Consortium (2002) Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 94(12):894\u2013903","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"9939_CR10","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.ejca.2010.01.027","volume":"46","author":"MC Fargnoli","year":"2010","unstructured":"Fargnoli MC, Gandini S, Peris K, Maisonneuve P, Raimondi S (2010) MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis. Eur J Cancer 46(8):1413\u20131420. doi: 10.1016\/j.ejca.2010.01.027","journal-title":"Eur J Cancer"},{"key":"9939_CR11","volume-title":"Cancer in Norway 2014\u2014cancer incidence, mortality, survival and prevalence in Norway","author":"Cancer Registry of Norway","year":"2015","unstructured":"Cancer Registry of Norway (2015) Cancer in Norway 2014\u2014cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway, Oslo"},{"issue":"2","key":"9939_CR12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/gcc.20518","volume":"47","author":"P Helsing","year":"2008","unstructured":"Helsing P, Nymoen DA, Ariansen S, Steine SJ, Maehle L, Aamdal S, Langmark F, Loeb M, Akslen LA, Molven A, Andresen PA (2008) Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas. Genes Chromosomes Cancer 47(2):175\u2013184","journal-title":"Genes Chromosomes Cancer"},{"key":"9939_CR13","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199510123331504","volume":"333","author":"AM Goldstein","year":"1995","unstructured":"Goldstein AM, Fraser MC, Struewing JP, Hussussian CJ, Ranade K, Zametkin DP, Fontaine LS, Organic SM, Dracopoli NC, Clark WH Jr, Tucker MA (1995) Increased risk of pancreatic cancer in melanoma-prone kindreds with p16ink4 mutations. N Engl J Med 333:970\u2013974","journal-title":"N Engl J Med"},{"issue":"6","key":"9939_CR14","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/1097-0215(20000915)87:6<809::AID-IJC8>3.0.CO;2-U","volume":"87","author":"HF Vasen","year":"2000","unstructured":"Vasen HF, Gruis NA, Frants RR, van Der Velden PA, Hille ET, Bergman W (2000) Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 87(6):809\u2013811","journal-title":"Int J Cancer"},{"issue":"20","key":"9939_CR15","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","volume":"66","author":"AM Goldstein","year":"2006","unstructured":"Goldstein AM, Chan M, Harland M, Gillanders EM, Hayward NK, Avril MF, Azizi E, Bianchi-Scarra G, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon Albright LA, Demenais F, Elder DE, Ghiorzo P, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, Mackie RM, Magnusson V, Mann GJ, Niendorf K, Newton Bishop J, Palmer JM, Puig S, Puig-Butille JA, de Snoo FA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E, Melanoma Genetics Consortium (GenoMEL) (2006) High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res 66(20):9818\u20139828","journal-title":"Cancer Res"},{"issue":"5","key":"9939_CR16","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jaad.2014.06.036","volume":"71","author":"M Potrony","year":"2014","unstructured":"Potrony M, Puig-Butille JA, Aguilera P, Bandenas C, Carrera C, Malvehy J, Puig S (2014) Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling. J Am Acad Dermatol 71(5):888\u2013895","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"9939_CR17","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/jnci\/djs221","volume":"104","author":"B Mukherjee","year":"2012","unstructured":"Mukherjee B, DeLancey JO, Raskin L et al (2012) Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers. JNCI 104(12):953\u2013956. doi: 10.1093\/jnci\/djs221","journal-title":"JNCI"},{"issue":"8","key":"9939_CR18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/jmedgenet-2014-102320","volume":"51","author":"H Helgadottir","year":"2014","unstructured":"Helgadottir H, H\u00f6iom V, J\u00f6nsson G, Tuominen R, Ingvar C, Borg \u00c5, Hansson J (2014) High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families. J Med Genet 51(8):545\u2013552","journal-title":"J Med Genet"},{"issue":"5","key":"9939_CR19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/ejhg.2014.187","volume":"23","author":"TP Potjer","year":"2015","unstructured":"Potjer TP, Kranenburg HE, Bergman W et al (2015) Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant. Eur J Hum Genet 23(5):711\u2013714. doi: 10.1038\/ejhg.2014.187","journal-title":"Eur J Hum Genet"},{"issue":"28","key":"9939_CR20","first-page":"3292","volume":"121","author":"T Levin","year":"2001","unstructured":"Levin T, Reichelt J, Heimdal K, M\u00f8ller P (2001) Informasjonsflyt i familier med arvelig bryst-og eggstokkreft. [Information to families with hereditary breast and ovarian cancer]. Tidsskr Nor Laegeforen 121(28):3292\u20133294","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"8","key":"9939_CR21","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/ajg.2010.120","volume":"105","author":"EM Stoffel","year":"2010","unstructured":"Stoffel EM, Mercado RC, Kohlmann W, Ford B, Grover S, Conrad P, Blanco A, Shannon KM, Powell M, Chung DC, Terdiman J, Gruber SB, Syngal S (2010) Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol 105(8):1851\u20131860","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"9939_CR22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10689-010-9368-z","volume":"9","author":"CR Lammens","year":"2010","unstructured":"Lammens CR, Bleiker EM, Aaronson NK, Wagner A, Sijmons RH, Ausems MG, Vriends AH, Ruijs MW, van Os TA, Spruijt L, G\u00f3mez Garc\u00eda EB, Cats A, Nagtegaal T, Verhoef S (2010) Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits. Fam Cancer 9(4):647\u2013654","journal-title":"Fam Cancer"},{"key":"9939_CR23","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/sj.bjc.6605942","volume":"103","author":"NA Kasparian","year":"2010","unstructured":"Kasparian NA, McLoone JK, Meiser B, Butow PN, Simpson JM, Mann GJ (2010) Skin cancer screening behaviours among individuals with a strong family history of malignant melanoma. Br J Cancer 103:1502\u20131509","journal-title":"Br J Cancer"},{"key":"9939_CR24","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1158\/1055-9965.EPI-08-0010","volume":"6","author":"LG Aspinwall","year":"2008","unstructured":"Aspinwall LG, Leaf SL, Dola ER, Kohlmann W, Leachman SA (2008) CDKN2A\/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families. Cancer Epidemiol Biomarkers Prev 6:1510\u20131519. doi: 10.1158\/1055-9965.EPI-08-0010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"9939_CR25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10897-005-0412-3","volume":"14","author":"CL Gaff","year":"2005","unstructured":"Gaff CL, Collins V, Symes T, Halliday J (2005) Facilitating family communication about predictive genetic testing probands\u2019 perceptions. J Genet Couns 14(2):133\u2013140","journal-title":"J Genet Couns"},{"issue":"1","key":"9939_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10897-012-9514-x","volume":"22","author":"J Hodgson","year":"2013","unstructured":"Hodgson J, Gaff C (2013) Enhancing family communication about genetics: ethical and professional dilemmas. J Genet Couns 22(1):16\u201321. doi: 10.1007\/s10897-012-9514-x","journal-title":"J Genet Couns"},{"key":"9939_CR27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1017\/CBO9780511570049.014","volume-title":"The troubled helix: social and psychological implications of the new human genetics","author":"M Richards","year":"1996","unstructured":"Richards M (1996) Families, kinship and genetics. In: Marteau T, Richards M\u00a0(eds) The troubled helix: social and psychological implications of the new human genetics. Cambridge University Press, New York, pp 249\u2013273"},{"issue":"1","key":"9939_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/gim.2011.3","volume":"14","author":"L Forrest","year":"2012","unstructured":"Forrest L, Delatycki M, Curnow L, Skene L, Aitken MA (2012) An audit of clinical service examining the uptake of genetic testing by at-risk family members. Genet Med 14(1):122\u2013128. doi: 10.1038\/gim.2011.3","journal-title":"Genet Med"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-016-9939-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-016-9939-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-016-9939-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:29:57Z","timestamp":1498357797000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-016-9939-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["9939"],"URL":"https:\/\/doi.org\/10.1007\/s10689-016-9939-8","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,1]]}}}